Frieda Gerdes, PhD

Find him/her on :

Specialization

Frieda Gerdes is a commercial and market access specialist in precision medicine with 25+ years of experience in molecular diagnostics and companion diagnostics. Trained as a cell and molecular biologist, she has held senior marketing and business development roles at leading diagnostics and pharma companies before founding Hello Healthcare Berlin GmbH. At Vim Vitae, she supports projects that require German market expertise, including launch planning and on‑the‑ground stakeholder engagement.

Key expertise areas

Notable engagements

Lead market access and marketing consultant e.g. for Oncotype Dx (Exact Sciences), clonoSEQ (Adaptive Biotechnologies) and the Merlin Gene Expression Assay (SkylineDx) in Germany.
Interim senior roles in clinical decision support and oncology diagnostics at Molecular Health and Cepheid.
Head of Marketing at Epigenomics AG, driving global marketing and launch of IVD tests for colorectal and lung cancer early detection.

Market and academic background

Frieda holds a PhD in Cell and Molecular Biology and a Master’s in Medical Microbiology from the University of Kiel, Germany. She started her career in sales and global marketing at Applied Biosystems / Thermo Fisher Scientific and later held leadership positions at GE Healthcare, Agendia, and Epigenomics, focusing on oncology diagnostics and precision medicine solutions.

Our team